Free Trial

VanEck Biotech ETF (BBH) Short Interest Ratio & Short Volume

→ LEAKED: Jeff Bezos' $330 Million Gamble (From Behind the Markets) (Ad)
Free BBH Stock Alerts
$164.59
+0.77 (+0.47%)
(As of 05/31/2024 ET)
Compare
Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends

VanEck Biotech ETF Short Interest Data

Current Short Interest
2,900 shares
Previous Short Interest
2,100 shares
Change Vs. Previous Month
+38.10%
Dollar Volume Sold Short
$489,085.00
Short Interest Ratio
0.4 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
2,620,000 shares
Percentage of Shares Shorted
0.11%
Today's Trading Volume
3,252 shares
Average Trading Volume
5,405 shares
Today's Volume Vs. Average
60%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling VanEck Biotech ETF ?

Sign up to receive the latest short interest report for VanEck Biotech ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BBH Short Interest Over Time

BBH Days to Cover Over Time

BBH Percentage of Float Shorted Over Time

VanEck Biotech ETF Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20242,900 shares $489,085.00 +38.1%N/A0.4 $168.65
4/30/20242,100 shares $327,684.00 -16.0%N/A0.3 $156.04
4/15/20242,500 shares $387,800.00 -68.0%N/A0.3 $155.12
3/31/20247,800 shares $1.30 million +212.0%N/A0.9 $166.33
3/15/20242,500 shares $407,950.00 +25.0%N/A0.3 $163.18
2/29/20242,000 shares $325,480.00 +185.7%N/A0.2 $162.74
2/15/2024700 shares $114,422.00 -22.2%N/A0.1 $163.46
1/31/2024900 shares $148,950.00 -87.3%N/A0.1 $165.50
1/15/20247,100 shares $1.20 million +97.2%N/A0.5 $168.38
12/31/20233,600 shares $595,116.00 -62.5%N/A0.3 $165.31
12/15/20239,600 shares $1.56 million -43.2%N/A0.8 $162.42
11/30/202316,900 shares $2.56 million +122.4%N/A1.8 $151.70
11/15/20237,600 shares $1.14 million +7.0%N/A1 $150.53
10/31/20237,100 shares $1.03 million -17.4%N/A1 $144.38
10/15/20238,600 shares $1.35 million +53.6%N/A1.2 $156.83
9/30/20235,600 shares $872,088.00 No ChangeN/A0.9 $155.73
9/15/20235,600 shares $897,344.00 -9.7%N/A0.8 $160.24
8/31/20236,200 shares $1.01 million +82.4%N/A1 $163.61
8/15/20233,400 shares $551,820.00 +70.0%N/A0.5 $162.30
7/31/20232,000 shares $321,560.00 -23.1%N/A0.3 $160.78
7/15/20232,600 shares $409,292.00 +8.3%N/A0.4 $157.42
6/30/20232,400 shares $374,520.00 -7.7%N/A0.4 $156.05
6/15/20232,600 shares $420,394.00 -13.3%N/A0.4 $161.69
5/31/20233,000 shares $463,890.00 No ChangeN/A0.4 $154.63
5/15/20233,000 shares $483,960.00 -52.4%N/A0.4 $161.32
4/30/20236,300 shares $1.01 million +14.6%N/A0.7 $159.73
4/15/20235,500 shares $913,165.00 +22.2%N/A0.5 $166.03
3/31/20234,500 shares $729,405.00 +95.7%N/A0.4 $162.09
3/15/20232,300 shares $360,479.00 +4.6%N/A0.2 $156.73
2/28/20232,200 shares $343,838.00 -74.1%N/A0.2 $156.29
2/15/20238,500 shares $1.40 million -38.0%N/A0.7 $164.77
1/31/202313,700 shares $2.30 million -38.6%N/A1 $167.74
1/15/202322,300 shares $3.75 million -9.0%N/A1.6 $168.27
12/30/202224,500 shares $3.91 million -9.9%N/A1.9 $159.74
12/15/202227,200 shares $4.51 million +115.9%N/A2 $165.75
11/30/202212,600 shares $2.12 million +106.6%N/A1 $168.16
11/15/20226,100 shares $1.02 million -80.7%N/A0.5 $166.95
10/31/202231,600 shares $4.97 million +182.1%N/A2.4 $157.23
10/15/202211,200 shares $1.63 million No ChangeN/A0.8 $145.46
9/30/20227,500 shares $1.06 million -33.6%N/A0.5 $140.78
“This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)

NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it.

A new breakthrough tech could add up to $20 trillion to the U.S. economy.
9/15/202211,300 shares $1.67 million +41.3%N/A0.7 $147.60
8/31/20228,000 shares $1.17 million -7.0%N/A0.4 $145.98
8/15/20228,600 shares $1.41 million -1.2%N/A0.4 $163.51
7/31/20228,700 shares $1.34 million -44.9%N/A0.3 $154.31
7/15/202215,800 shares $2.41 million -63.3%N/A0.6 $152.63
6/30/202243,100 shares $6.28 million +698.2%N/A1.7 $145.79
6/15/20225,400 shares $734,292.00 +12.5%N/A0.2 $135.98
5/31/20224,800 shares $710,352.00 -61.9%N/A0.2 $147.99
5/15/202212,600 shares $1.80 million -4.6%N/A0.6 $143.14
4/30/202213,200 shares $1.93 million -2.9%N/A0.6 $146.38
4/15/202213,600 shares $2.24 million +18.3%N/A0.6 $164.50
3/31/202211,500 shares $1.86 million -24.3%N/A0.5 $162.13
3/15/202215,200 shares $2.27 million -20.8%N/A0.6 $149.67
2/28/202219,200 shares $3.02 million -27.6%N/A0.7 $157.06
2/15/202226,500 shares $4.24 million -9.6%N/A1 $160.10
1/31/202229,300 shares $4.83 million +67.4%N/A1.2 $164.90
1/15/202217,500 shares $3.04 million -10.7%N/A0.8 $173.62
12/31/202119,600 shares $3.71 million +67.5%N/A1 $189.34
12/15/202111,700 shares $2.24 million -44.0%N/A0.6 $191.44
11/30/202120,900 shares $4.09 million -4.1%N/A1.2 $195.79
11/15/202121,800 shares $4.15 million +28.2%N/A1.4 $190.45
10/29/202117,000 shares $3.39 million -8.1%N/A1.1 $199.50
10/15/202118,500 shares $3.60 million -36.6%N/A1.2 $194.82
9/30/202129,200 shares $5.90 million +9.4%N/A1.8 $202.14
9/15/202126,700 shares $5.75 million -11.6%N/A1.8 $215.28
8/31/202130,200 shares $6.53 million -7.7%N/A2 $216.12
8/13/202132,700 shares $6.93 million +144.0%N/A2 $212.07
7/30/202113,400 shares $2.77 million -0.7%N/A0.8 $206.99
7/15/202113,500 shares $2.65 million -20.6%N/A0.9 $196.29
6/30/202117,000 shares $3.43 million -18.7%N/A1.2 $201.67
6/15/202120,900 shares $4.07 million -21.4%N/A1.5 $194.51
5/28/202126,600 shares $4.90 million +33.0%N/A2.3 $184.15
5/14/202120,000 shares $3.47 million +7.5%N/A1.8 $173.72
4/30/202118,600 shares $3.49 million +47.6%N/A1.5 $187.70
4/15/202112,600 shares $2.27 million -8.0%N/A1 $180.28
3/31/202113,700 shares $2.34 million +12.3%N/A1.1 $170.72
3/15/202112,200 shares $2.12 million -15.3%N/A0.9 $174.02
2/26/202114,400 shares $2.57 million -28.7%N/A1 $178.53
2/12/202120,200 shares $3.88 million +59.1%N/A1.2 $191.95
1/29/202112,700 shares $2.32 million -41.7%N/A0.7 $182.68
1/15/202121,800 shares $3.92 million +7.9%N/A1.3 $180.01
12/31/202020,200 shares $3.43 million -8.6%N/A1.2 $169.82
12/15/202022,100 shares $3.86 million -40.6%N/A1.3 $174.74
11/30/202037,200 shares $6.14 million -7.9%N/A2.1 $165.02
11/15/202040,400 shares $6.57 million +12.9%N/A2.2 $162.67
10/30/202035,800 shares $5.59 million -2.2%N/A1.9 $156.14
10/15/202036,600 shares $6.10 million -22.5%N/A0 $166.68
9/30/202047,200 shares $7.65 million -43.6%N/A2 $162.08
9/15/202045,100 shares $7.19 million -46.1%N/A1.6 $159.42
8/31/202083,700 shares $13.43 million -1.0%N/A2.8 $160.45
“This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)

NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it.

A new breakthrough tech could add up to $20 trillion to the U.S. economy.
8/14/202084,500 shares $13.64 million -13.4%N/A2.7 $161.45
7/31/202097,600 shares $16.09 million +4.7%N/A2.9 $164.85
7/15/202093,200 shares $15.87 million -17.7%N/A2.8 $170.33
6/30/2020113,200 shares $18.17 million +141.9%N/A3.3 $160.47
6/15/202046,800 shares $7.31 million +3.5%N/A1.4 $156.15
5/29/202045,200 shares $7.09 million -37.8%N/A1.3 $156.84
5/15/202072,700 shares $11.24 million +48.1%N/A2.1 $154.67
4/30/202049,100 shares $7.28 million -17.6%N/A1.6 $148.31
4/15/202059,600 shares $8.35 million -23.3%N/A2.1 $140.11
3/31/202077,700 shares $11.64 million +27.2%N/A3.2 $149.78
3/13/202061,100 shares $8.26 million +22.9%N/A1.7 $135.19
2/28/202049,700 shares $5.70 million -2.9%N/A2.7 $114.60
2/14/202051,200 shares $6.78 million +2.0%N/A3.4 $132.41
1/31/202050,200 shares $6.94 million +12.6%N/A3.4 $138.19
1/15/202044,600 shares $6.35 million +7.2%N/A3 $142.36
12/31/201941,600 shares $5.65 million -1.2%N/A3 $135.76

BBH Short Interest - Frequently Asked Questions

What is VanEck Biotech ETF's current short interest?

Short interest is the volume of VanEck Biotech ETF shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 2,900 shares of BBH short. Learn More on VanEck Biotech ETF's current short interest.

Is VanEck Biotech ETF's short interest increasing or decreasing?

VanEck Biotech ETF saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,900 shares, an increase of 38.1% from the previous total of 2,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does VanEck Biotech ETF's short interest compare to its competitors?

Here is how the short interest of companies compare to VanEck Biotech ETF: VanEck Pharmaceutical ETF (19.53%), Invesco S&P SmallCap Health Care ETF (0.03%), ProShares Ultra Nasdaq Biotechnology (0.74%), Principal Healthcare Innovators ETF (0.12%), Invesco Nasdaq Biotechnology ETF (0.71%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (7.41%), and iShares Biotechnology ETF (15.82%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short VanEck Biotech ETF stock?

Short selling BBH is an investing strategy that aims to generate trading profit from VanEck Biotech ETF as its price is falling. BBH shares are trading up $0.77 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against VanEck Biotech ETF?

A short squeeze for VanEck Biotech ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BBH, which in turn drives the price of the stock up even further.

How often is VanEck Biotech ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBH, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:BBH) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners
Dems have chosen Biden replacement?
Paradigm Press
Trump’s Gift Could Unleash $51 Billion in New Wealth
Wealthpin Pro
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
Nvidia has Apple and Microsoft within striking range
Weiss Ratings
Don’t buy a single NVIDIA share before you see this...
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
He Is Giving Away Bitcoin
Crypto Swap Profits